Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial

Lancet Neurology
E Nobile-OrazioIMC Trial Group

Abstract

Intravenous immunoglobulin (IVIg) and corticosteroids are effective as initial treatment in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), but little is known about the comparative risk-benefit profile of their long-term use in this disease. We compared the efficacy and tolerability of 6-month therapy with IVIg versus that with intravenous methylprednisolone. We did a multicentre, randomised, double-blind, placebo controlled, parallel-group study in patients with CIDP. We assessed efficacy and tolerability of IVIg (0·5 g/kg per day for 4 consecutive days) and intravenous methylprednisolone (0·5 g in 250 mL sodium chloride solution per day for 4 consecutive days) given every month for 6 months. Eligible patients had to be in an active or stationary phase of the disease. Allocation to treatment was centrally managed with a computer-generated, 1:1 randomisation scheme with a sequential block size of four. All patients and assessors were unaware of the treatment assignment. After therapy discontinuation, patients were followed up for 6 months to assess relapses. The primary outcome was the difference in the number of patients discontinuing either therapy owing to inefficacy or intolerance. Secondary...Continue Reading

References

Jun 1, 1989·Stroke; a Journal of Cerebral Circulation·J M BamfordJ Slattery
Apr 1, 1997·Journal of Neurology, Neurosurgery, and Psychiatry·D S MolenaarM Vermeulen
Aug 5, 1996·Transfusion Science·M S SternbachR Giammarco
Apr 21, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·M P LunnP K Thomas
Aug 17, 2001·Annals of Neurology·R HughesUNKNOWN Inflammatory Neuropathy Cause and Treatment (INCAT) Group
Mar 1, 2002·Muscle & Nerve·Ingemar S J MerkiesPieter A Van Doorn
Oct 28, 2003·Diabetes Care·Saul GenuthUNKNOWN Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
Dec 3, 2003·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Paul McCroneUNKNOWN INCAT Study Group
Mar 8, 2006·Journal of the Peripheral Nervous System : JPNS·Richard A C HughesNorman A Gregson
Apr 1, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·R C Graham, R A C Hughes
Nov 13, 2008·Archives of Neurology·Suraj Ashok MuleyGareth J Parry
Feb 24, 2010·Neurology·R A C HughesUNKNOWN Avonex CIDP Study Group

❮ Previous
Next ❯

Citations

Jun 19, 2013·Journal of Neurology·Pierre LozeronNathalie Kubis
Jun 25, 2013·Trends in Pharmacological Sciences·Mathias ButtmannHans-Peter Hartung
Dec 18, 2013·Immunotherapy·Melvin Berger
Apr 9, 2014·BMC Neurology·Filip EftimovUNKNOWN PREDICT study group
Jul 2, 2014·Nature Reviews. Neurology·Norman Latov
Sep 10, 2014·Revue neurologique·R Guimarães-CostaJ-M Léger
Aug 31, 2014·Autoimmunity Reviews·Maria Giovanna DanieliFrancesco Logullo
Nov 17, 2015·Expert Opinion on Pharmacotherapy·Paola Marmiroli, Guido Cavaletti
May 26, 2015·Journal of Neuroimmunology·Juliane KlehmetChristian Meisel
Nov 26, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Jean-Marc LégerCristina Muntean
Apr 30, 2013·La Presse médicale·Peter Y K Van den Bergh, Yusuf A Rajabally
May 7, 2013·Neurologic Clinics·Kenneth C Gorson, Jonathan Katz
May 23, 2015·Acta Neurologica Scandinavica·S Živković
Jan 16, 2014·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Stefano TamburinAndreas Goebel
Jun 27, 2015·Journal of the Peripheral Nervous System : JPNS·Els K VanhoutteUNKNOWN PeriNomS Study Group
Jul 22, 2014·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·E P FlanaganS J Pittock
Mar 13, 2014·Journal of the Peripheral Nervous System : JPNS·Eduardo Nobile-Orazio
Jul 24, 2015·Current Opinion in Neurology·Eduardo Nobile-Orazio, Francesca Gallia
Apr 12, 2014·Muscle & Nerve·Ari BreinerVera Bril
Jul 3, 2013·Postgraduate Medicine·Randy BroylesMelvin Berger
Sep 24, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·Eduardo Nobile-OrazioUNKNOWN IMC Trial Group
Apr 18, 2015·BMC Neurology·Elisabeth ChroniPanagiotis Papathanasopoulos
May 27, 2015·Current Neurology and Neuroscience Reports·Inna Kleyman, Thomas H Brannagan
Oct 16, 2015·Muscle & Nerve·Pierre LozeronDavid Adams
Oct 15, 2013·Journal of Neurology, Neurosurgery, and Psychiatry·Yusuf A Rajabally
Jul 19, 2014·Practical Neurology·A NeliganM P Lunn
Jan 8, 2015·Frontiers in Immunology·Jacqueline KerrHans-Hartmut Peter
Dec 4, 2014·Journal of the Neurological Sciences·Yusuf A Rajabally, Andrea E Cavanna
Jul 15, 2016·Nature Reviews. Rheumatology·Alain SarauxValérie Devauchelle-Pensec
Jul 19, 2016·Expert Opinion on Drug Metabolism & Toxicology·Livia DézsiLászló Vécsei
Jun 1, 2016·Journal of the Peripheral Nervous System : JPNS·Max E AdrichemIvo N van Schaik
Aug 30, 2016·Annals of Neurology·Dror MevorachAdi Tabib
Dec 22, 2016·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·L H MarkvardsenUNKNOWN Danish CIDP and MMN Study Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.